NHS screening spots signs of serious lung disease in 100,000 people, but there is no requirement to diagnose them[1] as hospitals brace for winter[2],[3],[4]
- The NHS Lung Cancer Screening Programme has delivered almost 1.3 million lung health checks and found more than 100,000 cases of emphysema, lung damage linked to COPD[5]
- But the programme is only required to tell a patient’s GP about the finding. There is no national requirement to test, diagnose and treat the people affected, and no dedicated national funding to do it[6]
- Breathing problems are the leading cause of emergency hospital admissions in England, accounting for one in eight, with more than 300,000 people admitted over a single winter[7]
- Where findings are followed up, the results are striking: in Hull, almost half of those assessed after screening were diagnosed with COPD, and over a quarter had been treated for a chest infection in the previous year[8]
- Former Government adviser and report author Richard Sloggett calls on the Government and NHS England to require that these findings are properly assessed, with dedicated funding for local health systems, spirometry testing closer to home and clear accountability for respiratory care
A new report from Future Health Research published on Monday 16 November – commissioned and funded by Chiesi Ltd, with the research undertaken independently by Future Health Research – finds that the NHS is identifying signs of serious lung disease in more than 100,000 people through lung cancer screening, but has no funded national pathway to diagnose and treat them.[9]
The NHS Lung Cancer Screening Programme offers a lung health check and a low-dose CT scan to people aged 55 to 74 with a history of smoking. It began in 2019 in the most deprived parts of England and is now being rolled out nationally. By April 2025 the programme had delivered 1,268,938 lung health checks, diagnosed 7,462 lung cancers,[10] around three quarters of them at an early stage,[11] and recorded 100,845 findings of emphysema.[12]
The report, Relieving an obstructed pathway, finds that the programme’s national standards only require that the finding of emphysema is communicated to the patient’s GP.[13] There is no national requirement, and no dedicated funding, for the spirometry test and clinical assessment needed to confirm a diagnosis of COPD and start treatment. The result is that many people receive a letter and nothing more, and the opportunity to act early is lost.
COPD affects around three million people in the UK and costs the NHS an estimated £1.9 billion a year.[14] [15] It is a progressive condition in which earlier diagnosis and treatment can slow the loss of lung function and reduce the flare-ups that lead to emergency admissions. Breathing problems are the leading cause of emergency hospital admissions in England, accounting for one in eight, and more than 300,000 people were admitted with breathing problems over a single winter.[16] More than a third of people with COPD (35%) are first diagnosed as an emergency, during or soon after an emergency admission or A&E attendance, by which point the disease is more advanced and more costly to treat.[17]
The warning comes as the Royal College of Emergency Medicine reports that 91% of A&E clinical leads are very or extremely concerned about the pressure they will face this winter, with only 3% saying their department is well prepared, describing “perfect conditions for a terrible winter”.[18]
The Relieving an obstructed pathway report shows what happens when findings are followed up. In Hull, where a dedicated clinic assesses people with emphysema identified through screening, 46.8% of those seen were diagnosed with COPD, and over a quarter had been treated for a chest infection in the year before their appointment.[19]
The report also finds that this is a health inequalities issue. The screening programme was deliberately targeted at the most deprived communities, where lung disease is most common. Future Health Research analysis of all 153 upper tier local authorities in England finds a strong link between deprivation and preventable deaths from respiratory disease, with the most deprived areas experiencing the highest rates.[20] Acting on the findings from screening is one of the most direct ways to narrow that gap.
The report calls on the Government and NHS England to:
- Require that patients are assessed: change the national standards for the screening programme so that significant findings of emphysema lead to a funded assessment rather than a letter to the GP
- Invest in the pathway: provide dedicated funding to integrated care boards, outside the cancer screening budget, to commission the spirometry test and clinical assessment
- Bring testing closer to home: make quality-assured spirometry available in the community, for example through primary care networks or community diagnostic services, so that people are not left waiting for a hospital appointment
- Improve accountability: ensure every integrated care board has an accountable lead for respiratory care, with a named clinical lead in each lead trust overseeing the screening programme and the pathway that follows it
Richard Sloggett, Founder and Programme Director of Future Health Research, former Government Special Adviser and report author said: “The NHS is already finding signs of serious lung disease in more than 100,000 people through lung cancer screening. In too many cases that finding goes no further than a letter to the GP. With breathing problems the leading cause of emergency admissions every winter, that is a missed opportunity to diagnose and treat people before they end up in A&E. The pathway exists but it is obstructed. The Government and NHS England need to require that these findings are properly assessed, fund local health systems to do it, and make sure every area has someone accountable for respiratory care. Done well, this would be prevention in action, ease the pressure on hospitals this winter and help tackle health inequalities.”
Sarah Sleet, CEO, Asthma + Lung UK, said: “Hundreds of thousands of people across England are living with undiagnosed lung conditions such as Chronic Obstructive Pulmonary Disease (COPD). The NHS is already doing the hard work of identifying people at risk and bringing them in for a lung health check. But if the scan shows lung disease, rather than lung cancer, too many people are being left without any meaningful follow up. It’s a missed opportunity to catch respiratory disease early, before people end up in hospital.
“At a time when the NHS faces lots of challenges and not many solutions, stopping people from falling through this diagnosis loophole is a no-brainer.
“With the right support and information, further testing and where appropriate referral to stop smoking services, people will be better able to manage their lung conditions, so they can stay well and out of hospital.”
Steve Holmes, Policy Lead at the Primary Care Respiratory Society (PCRS), said: “PCRS strongly believes that the lung cancer screening programme is important for earlier detection of lung cancer, but the other findings that are inevitable when scanning people in this age group should have appropriate resource to ensure further timely assessment and investigation when indicated to make earlier interventions in promoting health. This is especially important in people with COPD and with potential cardiac disease as well as other respiratory problems.”
Karl Hallberg, Vice President, Business Unit AIR, UK at Chiesi, said: “The Lung Cancer Screening Programme presents an important opportunity to identify people who may be living with undiagnosed respiratory disease, as well as detecting lung cancer earlier. What matters is that these findings lead to appropriate assessment and care, so that opportunities for earlier diagnosis are not missed.
“At Chiesi, we are committed to working in partnership with the NHS and the wider respiratory community to help address inequalities in respiratory health and improve outcomes for people living with conditions such as COPD. We welcome this report and the contribution it makes to the conversation about how we can make the most of the opportunities already being created through lung cancer screening.”
Contact information
Richard Sloggett
Programme Director, Future Health Research
richard@futurehealth-research.com
Notes to editors
The report, Relieving an obstructed pathway: building a national pathway for respiratory findings identified through lung cancer screening that can narrow health inequalities, will be available from 00:01 on Monday 16 November 2026 at www.futurehealth-research.com
This report was commissioned and funded by Chiesi Ltd. Full editorial control rests with Future Health Research.
More information on the NHS Lung Cancer Screening Programme, including its standard protocol and quality assurance standards, is available here: https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/
Figures on lung health checks, lung cancer diagnoses and incidental findings of emphysema are from a parliamentary written answer given by the Department of Health and Social Care on 25 July 2025 and cover the programme from its start to April 2025: https://questions-statements.parliament.uk/written-questions/detail/2025-07-14/67321
The Hull figures are from the FRONTIER Hull programme, a collaborative working project between Chiesi UK and Ireland and NHS Humber Health Partnership, presented at the European Respiratory Society International Congress in September 2025.
Emergency admissions figures are from Asthma + Lung UK analysis of NHS England data: https://www.asthmaandlung.org.uk/media/press-releases/breathing-issues-are-leading-cause-all-emergency-admissions
About Future Health Research
Future Health is a public policy research centre focused on creating healthier, wealthier people, communities and nations. The importance of prevention and the development of new technologies have long been seen as ways to transform health systems to improve patient outcomes and performance, but progress has often been slow. Future Health’s work across its three research programmes of health prevention, health technology and the links between improvements in health and economic growth exists to speed up the change that is needed.
https://www.futurehealth-research.com/
About Chiesi Group
Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.
By adopting the legal form of Benefit Corporation in Italy, the US, France and Colombia, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making. Chiesi is committed to the principles that underpin the B Corp movement and aims to reach Net-Zero greenhouse gas (GHG) emissions by 2035.
With 90 years of experience, Chiesi is headquartered in Parma (Italy), with 30 affiliates worldwide, and counts more than 7,900 employees. The Group’s research and development center in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.
For further information please visit www.chiesi.uk.com
UK-CHI-2600802 – October 2026
[1] NHS England, standard protocol and quality assurance standards for the Lung Cancer Screening Programme: findings of emphysema are communicated to the participant and their GP; the standards do not require or fund follow-up assessment. https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/
[2] Royal College of Emergency Medicine, press release, 20 October 2026: survey of 163 emergency department clinical leads across the UK (30 September to 2 October 2026) found 91% very or extremely concerned about winter pressures and only 3% saying their department was well prepared. https://rcem.ac.uk/press-release/perfect-conditions-for-a-terrible-winter-for-nhs-as-90-of-top-ae-doctors-worried-about-winter-pressures/
[3] Asthma + Lung UK, Breathing issues are the leading cause of all emergency admissions, 11 November 2024, based on NHS England Hospital Episode Statistics 2023/24 (13% of emergency admissions) and NHS England monthly respiratory admissions data for winter 2022/23 (334,415 admissions, December to March). https://www.asthmaandlung.org.uk/media/press-releases/breathing-issues-are-leading-cause-all-emergency-admissions
[4] Whitfield E, Lyratzopoulos G et al, PLOS Medicine, 2026 (reported by Health Data Research UK, 25 August 2026): analysis of linked NHS England data for over 1.7 million patients diagnosed with one of 13 conditions between 1999 and 2019 found that 35% of people with COPD were first diagnosed as an emergency, during or soon after an emergency admission or A&E attendance. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005182
[5] UK Parliament, written question 67321 (Lung Cancer: Screening), answered 25 July 2025: 1,268,938 lung health checks attended in England and 100,845 incidental findings of emphysema from the start of the programme to April 2025. https://questions-statements.parliament.uk/written-questions/detail/2025-07-14/67321 NHS website, Chronic obstructive pulmonary disease (COPD): COPD can include damage to the tiny air sacs inside the lungs (emphysema). https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/
[6] NHS England, standard protocol and quality assurance standards for the Lung Cancer Screening Programme: findings of emphysema are communicated to the participant and their GP; the standards do not require or fund follow-up assessment. https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/ Future Health Research, Relieving an obstructed pathway, November 2026.
[7] Asthma + Lung UK, Breathing issues are the leading cause of all emergency admissions, 11 November 2024, based on NHS England Hospital Episode Statistics 2023/24 (13% of emergency admissions) and NHS England monthly respiratory admissions data for winter 2022/23 (334,415 admissions, December to March). https://www.asthmaandlung.org.uk/media/press-releases/breathing-issues-are-leading-cause-all-emergency-admissions
[8] Chiesi UK and Ireland press release, 30 September 2025, FRONTIER Hull data reveals 50% diagnosis rate in COPD case-finding programme: 46.8% (n=383) of people assessed were diagnosed with COPD and over 25% (n=98) had a reported chest infection in the preceding year. Data presented at the ERS International Congress 2025. https://www.chiesi.uk.com/media/press-releases/frontier-hull-data-reveals-diagnosis-rate-in-copd
[9] NHS England, standard protocol and quality assurance standards for the Lung Cancer Screening Programme: findings of emphysema are communicated to the participant and their GP; the standards do not require or fund follow-up assessment. https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/
[10] UK Parliament, written question 67321 (Lung Cancer: Screening), answered 25 July 2025. From the start of the programme to April 2025, 1,268,938 lung health checks were attended in England, 7,462 lung cancers diagnosed and 100,845 incidental findings of emphysema recorded. https://questions-statements.parliament.uk/written-questions/detail/2025-07-14/67321
[11] Lee RW, Nair A, Balata H et al, Implementation of the NHS England Lung Cancer Screening Programme over 5 years, Nature Medicine 2026;32(5):1817–1826: 76% of screen-detected lung cancers were diagnosed at stage 1 or 2. https://doi.org/10.1038/s41591-026-04292-y
[12] UK Parliament, written question 67321 (Lung Cancer: Screening), answered 25 July 2025. From the start of the programme to April 2025, 1,268,938 lung health checks were attended in England, 7,462 lung cancers diagnosed and 100,845 incidental findings of emphysema recorded. https://questions-statements.parliament.uk/written-questions/detail/2025-07-14/67321
[13] NHS England, Targeted screening for lung cancer with low radiation dose computed tomography: standard protocol and quality assurance standards for the Lung Cancer Screening Programme. https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/
[14] NICE Clinical Knowledge Summaries, Chronic obstructive pulmonary disease: how common is it? https://cks.nice.org.uk/topics/chronic-obstructive-pulmonary-disease/background-information/prevalence-incidence/
[15] NHS England, Respiratory high impact interventions. https://www.england.nhs.uk/ourwork/prevention/secondary-prevention/respiratory-high-impact-interventions/
[16] Asthma + Lung UK, Breathing issues are the leading cause of all emergency admissions, 11 November 2024, based on NHS England Hospital Episode Statistics 2023/24 and NHS England monthly respiratory admissions data for winter 2022/23 (December to March). https://www.asthmaandlung.org.uk/media/press-releases/breathing-issues-are-leading-cause-all-emergency-admissions
[17] Whitfield E, Lyratzopoulos G et al, PLOS Medicine, 2026 (reported by Health Data Research UK, 25 August 2026): analysis of linked NHS England data for over 1.7 million patients diagnosed with one of 13 conditions between 1999 and 2019 found that 35% of people with COPD were first diagnosed as an emergency, during or soon after an emergency admission or A&E attendance. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005182
[18] Royal College of Emergency Medicine, press release, 20 October 2026: survey of 163 emergency department clinical leads across the UK (30 September to 2 October 2026) found 91% very or extremely concerned about winter pressures and only 3% saying their department was well prepared. https://rcem.ac.uk/press-release/perfect-conditions-for-a-terrible-winter-for-nhs-as-90-of-top-ae-doctors-worried-about-winter-pressures/
[19] Chiesi UK and Ireland press release, 30 September 2025, FRONTIER Hull data reveals 50% diagnosis rate in COPD case-finding programme, reporting data presented at the European Respiratory Society International Congress 2025. https://www.chiesi.uk.com/media/press-releases/frontier-hull-data-reveals-diagnosis-rate-in-copd
[20] Future Health Research analysis of preventable respiratory mortality (Office for Health Improvement and Disparities, Fingertips) against the Index of Multiple Deprivation 2019 for 153 upper tier local authorities in England. Full method in the report.